Obesity and the risk and prognosis of gallstone disease and pancreatitis

被引:112
作者
Bonfrate, Leonilde [1 ]
Wang, David Q-H. [2 ]
Garruti, Gabriella [3 ]
Portincasa, Piero [4 ]
机构
[1] Univ Bari, Sch Med, Residency Programme Internal Med, I-70124 Bari, Italy
[2] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, St Louis, MO 63104 USA
[3] Univ Bari, Sch Med, Sect Endocrinol Androl & Metab Dis, Dept Emergency & Organ Transplants, I-70124 Bari, Italy
[4] Univ Bari, Sch Med, Clin Med A Murri, Dept Biomed Sci & Human Oncol, I-70124 Bari, Italy
基金
美国国家卫生研究院;
关键词
Bariatric surgery; Cholecystectomy; Cholesterol; Gallbladder motility; Metabolic syndrome; Rapid weight loss; Y GASTRIC BYPASS; PREVIOUS ABDOMINAL-SURGERY; RAPID WEIGHT-LOSS; LOW-CALORIE DIET; BODY-MASS INDEX; URSODEOXYCHOLIC ACID; GALLBLADDER-DISEASE; BARIATRIC SURGERY; SYMPTOMATIC GALLSTONES; DOUBLE-BLIND;
D O I
10.1016/j.bpg.2014.07.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Obesity is a risk factor for the formation of cholesterol gallstones and exposes patients to increased risk of gallstone-related complications and cholecystectomy. Rapid weight loss achieved by very low calorie diets or bariatric surgery is also a risk factor for cholelithiasis in obese patients, and therapy should take into account the higher prevalence of gallstones, the possibility of more frequent complications and the need for prophylactic treatment with oral ursodeoxycholic acid during weight loss. Obesity is also frequent in children and adolescents, and the burden of cholesterol cholelithiasis is increasing in this population. The chance to develop acute pancreatitis and the severity of the disease are higher in obese subjects because of specific pathogenic factors, including supersaturated bile and crystal formation, rapid weight loss, and visceral obesity. All health policies aimed at reducing the incidence of obesity worldwide will decrease the incidence of gallstones and gallstone-related complications. The pathophysiological scenarios and the therapeutic implications for obesity, gallstone disease, and pancreatitis are discussed. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:623 / 635
页数:13
相关论文
共 119 条
[1]
GALLBLADDER-DISEASE IN THE MORBIDLY OBESE [J].
AMARAL, JF ;
THOMPSON, WR .
AMERICAN JOURNAL OF SURGERY, 1985, 149 (04) :551-557
[2]
[Anonymous], J PEDIAT SURG
[3]
ATTILI AF, 1988, HEPATOLOGY, V8, P904
[4]
Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis [J].
Blomgren, KB ;
Sundström, A ;
Steineck, G ;
Wiholm, BE .
DIABETES CARE, 2002, 25 (02) :298-302
[5]
A woman with abdominal pain and weakness after gastric bypass surgery - Acute porphyria (variegate porphyria) [J].
Bonkovsky, Herbert L. ;
Siao, Peter ;
Roig, Zulmarie ;
Hedley-Whyte, E. Tessa ;
Flotte, Thomas J. ;
Bloom, Allyson K. ;
Harris, Nancy Lee ;
Buonanno, Ferdinando S. ;
Gonzalez, Ernesto .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) :2813-2825
[6]
EFFECTS OF URSODEOXYCHOLIC ACID AND ASPIRIN ON THE FORMATION OF LITHOGENIC BILE AND GALLSTONES DURING LOSS OF WEIGHT [J].
BROOMFIELD, PH ;
CHOPRA, R ;
SHEINBAUM, RC ;
BONORRIS, GG ;
SILVERMAN, A ;
SCHOENFIELD, LJ ;
MARKS, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (24) :1567-1572
[7]
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults [J].
Chen, Chien-Hua ;
Huang, Min-Ho ;
Yang, Jee-Chun ;
Nien, Chiu-Kue ;
Yang, Chi-Chieh ;
Yeh, Yung-Hsiang ;
Yueh, Sen-Kou .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (08) :745-752
[8]
Metabolic syndrome and gallstone disease [J].
Chen, Li-Ying ;
Qiao, Qiao-Hua ;
Zhang, Shan-Chun ;
Chen, Yu-Hao ;
Chao, Guan-Qun ;
Fang, Li-Zheng .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (31) :4215-4220
[9]
Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic [J].
Colli, A. ;
Conte, D. ;
Della Valle, S. ;
Sciola, V. ;
Fraquelli, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) :1370-1378
[10]
Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]